CorMedix Inc. (CRMD)
NASDAQ·Healthcare·Biotechnology
$7.58
-3.13%
Mkt Cap $586.55M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | $127.02M | $128.62M | +1.26% | $0.86 | $0.61 | -29.07% | — | — |
| Q4 2025 Nov 12, 2025 | $127.02M | $104.28M | -17.91% | $0.48 | $0.57 | +18.75% | — | — |
| Q3 2025 Aug 7, 2025 | $42.46M | $39.74M | -6.41% | $0.20 | $0.28 | +40.00% | — | — |
| Q2 2025 May 6, 2025 | $29.88M | $39.08M | +30.80% | $0.25 | $0.30 | +20.00% | — | — |
| Q1 2025 Mar 25, 2025 | $31.27M | $31.21M | -0.19% | $0.17 | $0.22 | +29.41% | — | — |
| Q4 2024 Oct 30, 2024 | $19.79M | $11.46M | -42.11% | -$0.10 | -$0.05 | +50.00% | — | — |
| Q3 2024 Aug 14, 2024 | $1.67M | $806.12K | -51.73% | -$0.26 | -$0.25 | +3.85% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.27 | -$0.25 | +7.41% | — | — |
| Q1 2024 Mar 12, 2024 | -$250.00K | $304.11K | +221.64% | -$0.21 | -$0.26 | -23.81% | — | — |
| Q4 2023 Nov 14, 2023 | -$250.00K | — | — | -$0.21 | -$0.17 | +19.05% | — | — |
| Q3 2023 Aug 8, 2023 | — | — | — | -$0.22 | -$0.25 | -13.64% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$0.20 | -$0.24 | -20.00% | — | — |
| Q1 2023 Mar 30, 2023 | $2.33K | $29.70K | +1173.12% | -$0.19 | -$0.20 | -5.26% | — | — |
| Q4 2022 Nov 10, 2022 | — | $6.82K | — | -$0.23 | -$0.17 | +26.09% | — | — |
| Q3 2022 Aug 11, 2022 | — | $21.25K | — | -$0.20 | -$0.19 | +5.00% | — | — |
| Q2 2022 May 12, 2022 | $25.00K | $7.64K | -69.46% | -$0.23 | -$0.18 | +21.74% | — | — |
| Q1 2022 Mar 29, 2022 | $19.00K | $56.40K | +196.83% | -$0.22 | -$0.20 | +9.09% | — | — |
| Q4 2021 Nov 9, 2021 | $20.00K | $38.09K | +90.44% | -$0.18 | -$0.22 | -22.22% | — | — |
| Q3 2021 Aug 12, 2021 | $40.00K | $8.19K | -79.52% | -$0.18 | -$0.12 | +33.33% | — | — |
| Q2 2021 May 13, 2021 | $2.87K | $88.26K | +2980.66% | -$0.18 | -$0.20 | -11.11% | — | — |